What is Physera?
Physera operates at the intersection of physical therapy and digital health, providing a comprehensive virtual care program designed to manage musculoskeletal issues. By leveraging a nationwide network of licensed physical therapists alongside proprietary digital tools, the company delivers personalized treatment plans that facilitate long-term recovery. Its market position is defined by a focus on measurable clinical efficacy, with data indicating high member satisfaction and substantial year-one cost savings. As a key player in the digital therapeutics sector, Physera integrates seamlessly into existing benefit ecosystems, offering a scalable alternative to traditional, in-person clinical care models.
How much funding has Physera raised?
Physera has raised a total of $10.8M across 2 funding rounds:
Private Equity
$2.8M
Series A
$8M
Private Equity (2017): $2.8M with participation from Lux Capital, Expa, Innovation Endeavors, and Slow Ventures
Series A (2019): $8M, investors not publicly disclosed
Key Investors in Physera
Lux Capital
Lux Capital is a New York based venture capital firm that raises dedicated funds to invest in earlystage and growthstage companies at the intersection of science and technology, backing founders in frontier areas such as AI, robotics, space, defense, biotechnology, and advanced materials from seed through IPO or acquisition.
Expa
Expa is the best place for entrepreneurs to create and launch new companies. Started in 2014 by Uber co-founder Garrett Camp, Expa's partners and team are dedicated to bringing the best ideas to market, offering access to proven entrepreneurs, capital, and the network to build new companies.
Innovation Endeavors
Innovation Endeavors is an early-stage venture capital firm that invests in visionary founders, transformational technologies and emergent ecosystems, focusing on the Super Evolution thesis which combines data and advanced engineering to transform industries.
What's next for Physera?
With the successful closure of its latest financing round, Physera is well-positioned to accelerate its enterprise-level expansion. The strategic deployment of this capital will likely focus on enhancing its technological infrastructure, expanding its network of licensed practitioners, and deepening its penetration within the employer and health plan segments. As the digital health market continues to consolidate, Physera's focus on evidence-based MSK outcomes provides a competitive moat, enabling the company to scale its operations while maintaining the high-touch, personalized care standards that have defined its growth to date. Future milestones will likely center on further integration with large-scale health benefit consultants to drive broader adoption of its virtual care pathways.
See full Physera company page
